 RALEIGH, NC ACCESSWIRE October 19, 2021 9 Meters Biopharma, Inc. NASDAQ:NMTR, a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases by studying unique GI biology, announced today that the company will deliver a poster presentation highlighting vurolenatide, 9 Meters therapeutic candidate in short bowel syndrome, and will host a booth exhibit at the in-person component of the American College of Gastroenterology ACG 2021 Annual Scientific Meeting, held in a hybrid format both virtually and in Las Vegas, Nevada on October 22 - 27, 2021. Participation Details: Poster Poster number: P3006 Location: Mandalay Bay Convention Center, Shoreline Exhibit Hall Presenter: Patrick H. 